About this trial
The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.
Eligibility criteria
Qualifiers
Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)
Treatment including chemotherapy and/or radiation therapy
Completion of all cancer therapy for at least 6 months and less than 2 years
Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
Disqualifiers
Undergoing active cancer treatment
Patient under the care of the Late Effects Program at St. Louis Children's Hospital
Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.
Parents and/or patient illiteracy
Trial design
Treatments tested in this trial
- Highlighting Patients at Risk for Sensory Screening (HPARSS)
Treatment groups
Sponsors and collaborators
Washington University School of Medicine
Lead sponsor
St. Jude Children's Research Hospital
Collaborator